JP2024515879A5 - - Google Patents
Info
- Publication number
- JP2024515879A5 JP2024515879A5 JP2023566870A JP2023566870A JP2024515879A5 JP 2024515879 A5 JP2024515879 A5 JP 2024515879A5 JP 2023566870 A JP2023566870 A JP 2023566870A JP 2023566870 A JP2023566870 A JP 2023566870A JP 2024515879 A5 JP2024515879 A5 JP 2024515879A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182271P | 2021-04-30 | 2021-04-30 | |
| US63/182,271 | 2021-04-30 | ||
| PCT/US2022/027006 WO2022232558A1 (en) | 2021-04-30 | 2022-04-29 | Anti-siglec compositions and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024515879A JP2024515879A (ja) | 2024-04-10 |
| JP2024515879A5 true JP2024515879A5 (https=) | 2025-03-17 |
| JPWO2022232558A5 JPWO2022232558A5 (https=) | 2025-03-17 |
Family
ID=83848703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566870A Pending JP2024515879A (ja) | 2021-04-30 | 2022-04-29 | 抗ｓｉｇｌｅｃ組成物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240218067A1 (https=) |
| EP (1) | EP4329806A4 (https=) |
| JP (1) | JP2024515879A (https=) |
| KR (1) | KR20240006519A (https=) |
| CN (1) | CN117355331A (https=) |
| AU (1) | AU2022267362A1 (https=) |
| CA (1) | CA3216324A1 (https=) |
| IL (1) | IL308137A (https=) |
| MX (1) | MX2023012759A (https=) |
| TW (1) | TW202305005A (https=) |
| WO (1) | WO2022232558A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117643575B (zh) * | 2023-11-03 | 2026-04-24 | 中山大学 | 一种纳米材料及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120171114A1 (en) * | 2008-04-11 | 2012-07-05 | Haeuw Jean-Francois | Anti-cd151 antibodies and their use in the treatment of cancer |
| US8163281B2 (en) * | 2009-03-04 | 2012-04-24 | The Regents Of The University Of Michigan | Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis |
| TW201612518A (en) * | 2014-01-17 | 2016-04-01 | Sanofi Sa | Methods of identifying patients suffering from liver cancer who will most likely benefit from a treatment with an antagonist anti-FGFR4 antibody |
| CA3004972A1 (en) * | 2015-11-17 | 2017-05-26 | Innate Pharma | Siglec-10 antibodies |
| KR20210143868A (ko) * | 2019-03-26 | 2021-11-29 | 포티 세븐, 인코포레이티드 | 암 치료용 다중특이성 제제 |
-
2022
- 2022-04-29 TW TW111116333A patent/TW202305005A/zh unknown
- 2022-04-29 MX MX2023012759A patent/MX2023012759A/es unknown
- 2022-04-29 EP EP22796839.3A patent/EP4329806A4/en active Pending
- 2022-04-29 KR KR1020237036789A patent/KR20240006519A/ko active Pending
- 2022-04-29 CN CN202280031124.9A patent/CN117355331A/zh active Pending
- 2022-04-29 WO PCT/US2022/027006 patent/WO2022232558A1/en not_active Ceased
- 2022-04-29 JP JP2023566870A patent/JP2024515879A/ja active Pending
- 2022-04-29 AU AU2022267362A patent/AU2022267362A1/en active Pending
- 2022-04-29 US US18/558,112 patent/US20240218067A1/en active Pending
- 2022-04-29 CA CA3216324A patent/CA3216324A1/en active Pending
- 2022-04-29 IL IL308137A patent/IL308137A/en unknown